Filter
1543
Filtered Results: 1543
Text search:
Ethics
in
Health
Research
Featured
Recommendations
124
New Publications
381
Language
Document type
No document type
849
Studies & Reports
339
Guidelines
176
Manuals
97
Strategic & Response Plan
31
Training Material
28
Fact sheets
16
Situation Updates
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
68
Global
52
South Africa
51
Kenya
50
Sierra Leone
45
Nigeria
32
Ethiopia
31
Malawi
29
Uganda
29
Rwanda
28
Tanzania
26
Western and Central Europe
26
Liberia
25
Zambia
23
Myanmar / Burma
22
Eastern Europe
20
Latin America and the Carribbean
19
Lesotho
18
Ghana
17
Africa
17
Syria
16
Bangladesh
16
Ukraine
15
Senegal
13
Middle East and North Africa
12
Botswana
12
Nepal
11
Congo, Democratic Republic of
11
Brazil
11
Russia
11
Cambodia
10
West and Central Africa
10
Benin
9
Guinea
9
Mozambique
9
Indonesia
9
Burkina Faso
8
Philippines
8
South–East Asia Region
8
East and Southern Africa
8
Tajikistan
7
Cameroon
7
Germany
7
South Sudan
7
Zimbabwe
6
Vietnam
6
Namibia
6
Yemen
6
Eastern Europe and Central Asia
4
Southern Africa
4
Somalia
4
Ecuador
4
Colombia
3
Thailand
3
China
3
Kazakhstan
3
Kyrgyzstan
3
Peru
3
Haiti
3
Spain
3
Moldova
3
Angola
3
Eswatini/ Swaziland
3
Pakistan
3
El Salvador
2
Turkey
2
Laos
2
Afghanistan
2
Armenia
2
Asia
2
Saudi Arabia
2
Paraguay
2
United Kingdom
2
Portugal
2
Bosnia and Herzegovina
2
Argentina
2
Lebanon
2
Sri Lanka
2
Sudan
2
Georgia
2
Mali
2
Libya
2
Iraq
2
Madagascar
2
Guatemala
2
North Macedonia
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Chile
1
Iran
1
Albania
1
Canada
1
Uzbekistan
1
Malaysia
1
Qatar
1
Italy
1
Venezuela
1
Jordan
1
Western Pacific Region
1
Japan
1
France
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Djibouti
1
Egypt
1
Palestine
1
Central African Republic
1
Chad
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
617
Clinical Guidelines
104
Women & Child Health
85
Key Resources
70
Public Health
67
Capacity Building
19
Pharmacy & Technologies
15
Annual Report MEDBOX
3
Toolboxes
HIV
131
COVID-19
125
TB
117
Mental Health
104
Caregiver
85
Ebola & Marburg
48
Disability
43
Social Ethics
43
NTDs
43
Rapid Response
42
Planetary Health
42
Global Health Education
38
NCDs
26
AMR
26
Conflict
23
Pharmacy
22
Refugee
16
Health Financing Toolbox
14
Zika
11
Polio
7
Cholera
6
Natural Hazards
4
Specific Hazards
3
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...
In May 2017, the World Health Assembly adopted resolutio...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
Preliminary overview of refugees and migrants self-reported impact of COVID-19
The study surveyed over 30,000 refugees and migrants living in 170 countries. Many of the respondents had fled war or dire economic conditions in their home country only to be faced with the additional challenges posed b...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
Guidance module.
The QualityRights training and orientation modules have been developed to enhance the knowledge, skills and understanding of key stakeholders on how to promote the rights of people with psychosocial, intellectual or cognitive disabilities, improve the quality of services and suppo...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district bein...
An all-hazards tool for hospital administrators and emergency managers.
The World Health Organization Regional Office for Europe has developed the Hospital emergency response checklist to assist hospital administrators and emergency managers in responding effectively to the most likely disaster sce...
At the end of 2023, WHO convened our first-ever annual WHO Stakeholder Review Conference for Prevention and Response to Sexual Misconduct. Aimed at joint learning and frank discussion on challenges faced in the achieving zero tolerance for all forms of sexual misconduct by aid workers, the Conferenc...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
